Related Experiment Video
Updated: Sep 26, 2025

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.1K
Plg-RKT Expression in Human Breast Cancer Tissues
Lindsey A Miles1, Stan Krajewski2, Nagyung Baik1
1Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
Biomolecules
|April 23, 2022
Summary
Plasminogen Receptor KT (Plg-RKT) is widely expressed in breast tumors and increases with cancer spread. Its expression is highest in aggressive, hormone receptor-positive tumors, suggesting a role in breast cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The plasminogen activation system regulates plasmin activity, crucial for tissue remodeling.
- Plasminogen receptors modulate the tumor microenvironment and are key in cancer progression.
- Plg-RKT is a unique integral membrane plasminogen receptor binding via a C-terminal lysine.
Purpose of the Study:
- To investigate the expression of Plg-RKT in human breast tumors and cell lines.
- To correlate Plg-RKT expression with breast cancer progression and characteristics.
Main Methods:
- Tissue microarrays of breast cancer progression were probed with anti-Plg-RKT monoclonal antibodies.
- Western blotting was used to detect Plg-RKT in breast cancer cell lines.
- Flow cytometry assessed Plg-RKT cell surface expression on aggressive tumor cell lines.
Main Results:
- Plg-RKT is widely expressed in human breast tumors.
- Increased Plg-RKT expression correlates with tumor spread to lymph nodes and distant organs.
- Plg-RKT expression is most pronounced in hormone receptor-positive tumors and highest on aggressive cell lines.
Conclusions:
- Plg-RKT is broadly expressed in breast tumors and its expression correlates with advanced disease.
- Plg-RKT may play a significant role in breast cancer progression, particularly in hormone receptor-positive subtypes.
- Further research into Plg-RKT functions in breast cancer is warranted.
More Related Videos
Related Concept Videos
The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K

